Tag: IVI
IVI & Bharat Biotech begin Chikungunya vaccine trials in Costa Rica
Phase II and III trials are funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology (DBT), India.............................
IVI & Bharat Biotech get US $14.1 million from CEPI to...
The Coalition for Epidemic Preparedness Innovations (CEPI) will provide consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) with up to US$14.1 million for vaccine manufacturing and clinical development of a two-dose live-inactivated vaccine (BBV87) against Chikungunya..............